A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tobacco Cessation
- Sponsor
- Truth Initiative
- Enrollment
- 2588
- Locations
- 1
- Primary Endpoint
- Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT)
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.
Detailed Description
The Quit Vaping Study (QVS)'s primary aim is to conduct a fully powered comparative effectiveness trial to evaluate the effectiveness of a quit vaping text message program in promoting abstinence from e-cigarettes among young users aged 18-24. This study is a 2-arm randomized controlled trial conducted among young users aged 18-24 recruited through online channels. Participants will be randomized to a quit vaping text message intervention or to an assessment-only control condition and followed for 7 months to roughly correspond to 6-months post-treatment. The secondary aim is to examine potential mediators of program effectiveness, including treatment engagement and changes in self-efficacy and perceived social support for quitting.
Investigators
Amanda L. Graham, PhD
Chief of Innovations
Truth Initiative
Eligibility Criteria
Inclusion Criteria
- •Age 18-24
- •Past 30-day use of e-cigarettes containing nicotine
- •Interest in quitting e-cigarette use in the next 30 days
- •US residence
Exclusion Criteria
- •Failure to confirm mobile number after initial sign-up
Outcomes
Primary Outcomes
Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT)
Time Frame: 7 months post enrollment
Number of participant who responded "No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is all randomized participants.
Secondary Outcomes
- Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT)(7 months post enrollment)
- Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only)(7 month post enrollment)
- Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only)(7 months post enrollment)